Search Results 811-820 of 18029 for infertility

  1. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  2. Decitabine (intravenous route) - Side effects & uses - Mayo Clinic

    Some men receiving this medicine have become infertile (unable to have children). Back to top. Side Effects. Along with its needed effects, a medicine may ...

  3. Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) - Mayo Clinic

    About this study. The purpose of this study is to compare the effects of 5g of TU-100 three times per day (TU-100 is a botanical agent that modulates ...

  4. A Study to Evaluate Gene Therapy to Treat Neovascular Age-related Macular Degeneration - Mayo Clinic

    The primary objective of this study is to evaluate mean change in best-corrected visual acuity (BCVA) of RGX-314 relative to ranibizumab at Week 38. Second ...

  5. Neurofibromatosis type 1 - Symptoms and causes - Mayo Clinic

    This genetic condition causes tumors on nerve tissue. Surgery and other therapies can manage symptoms.

  6. Science Saturday: Mayo Clinic advances pain management beyond opioids

    Sharing Mayo Clinic: A long road through infertility to parenthood. Related Articles. Harnessing telehealth to enhance patient care featured image. Featured ...

  7. Optimizing Rehabilitation Effect with Electrical Stimulation Therapy Rehab - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation (DBS) of the dentate nucleus area for improving functional ...

  8. Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  9. Publications - Wendaline M. VanBuren, M.D. - Mayo Clinic

    Endometriosis: a journey from infertility to fertility. Abdom Radiol (NY). 2025 Nov; 50 (11):5405-5421 Epub 2025 Apr 15. View PubMed; Callori S, VanBuren W ...

  10. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...